Stay updated on Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Sign up to get notified when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a government-funding-status notice and a new system revision tag (Revision: v3.4.1); the prior revision tag (Revision: v3.4.0) was removed.
    Difference
    0.7%
    Check dated 2026-02-04T00:40:20.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle and color-coded highlights for additions and deletions (green and red). The latest revision is shown as v3.4.0, replacing the previous v3.3.4.
    Difference
    0.8%
    Check dated 2026-01-28T00:27:12.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed from the Record History, a minor update to the page's version log that does not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:30:20.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The record history now includes Revision: v3.3.3, and the footer no longer displays HHS Vulnerability Disclosure or Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T08:37:30.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    New revision entry v3.3.2 appears in the record history, and the v3.2.0 entry is removed.
    Difference
    0.1%
    Check dated 2025-11-24T17:47:57.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Removed a generic government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-17T17:22:28.000Z thumbnail image

Stay in the know with updates to Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.